Filing Details

Accession Number:
0001209191-19-061469
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-12-20 12:54:18
Reporting Period:
2019-12-19
Accepted Time:
2019-12-20 12:54:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1262104 Mei Pharma Inc. MEIP Pharmaceutical Preparations (2834) 510407811
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1288233 Phd P Daniel Gold C/O Mei Pharma, Inc.
3611 Valley Centre Drive, Suite 500
San Diego CA 92130
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-12-19 18,750 $1.60 361,632 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct